Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
The Battery Show Europ...The Battery Show Europe
Not Confirmed
Not Confirmed
03-05 June, 2025
Chemspec EuropeChemspec Europe
Not Confirmed
Not Confirmed
04-05 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
The Battery Show Europ...The Battery Show Europe
Industry Trade Show
Not Confirmed
03-05 June, 2025
Chemspec EuropeChemspec Europe
Industry Trade Show
Not Confirmed
04-05 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
31 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/derick-cooper-ceo-of-qol-medical-llc-strengthens-commitment-to-faith-based-giving-with-major-donations-to-religious-organizations-302420591.html
21 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/derick-cooper-ceo-of-qol-medical-llc-donates-75-000-to-support-beacon-rescue-and-disaster-relief-efforts-302407739.html
01 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sucraid-sacrosidase-oral-solution-free-4-day-trial-now-available-the-only-fda--approved-therapy-to-treat-csid-congenital-sucrase-isomaltase-deficiency-302389214.html
02 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020772
06 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/qol-medical-llc-receives-fda-approval-of-sucraid-sacrosidase-oral-solution-single-use-containers-for-patients-with-congenital-sucrase-isomaltase-deficiency-csid-301618690.html
ABOUT THIS PAGE